Evidence map›Paper›PMID 30940712›Full record

ArticlemBio2019

Effects of a Novel Probiotic Combination on Pathogenic Bacterial-Fungal Polymicrobial Biofilms.

Christopher L Hager, Nancy Isham, Kory P Schrom, Jyotsna Chandra, Thomas McCormick, Masaru Miyagi, Mahmoud A Ghannoum

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Microorganisms · 2025
    Article
  8. Review
  9. Mycobiome: an underexplored kingdom in cancer.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  10. Intestinal dysbiosis and colorectal cancer.Chinese medical journal · 2025
    Review
  11. Review
  12. The Gut Mycobiome for Precision Medicine.Journal of fungi (Basel, Switzerland) · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christopher L HagerCenter for Medical Mycology, Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
Nancy IshamCenter for Medical Mycology, Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
Kory P SchromUniversity Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Jyotsna ChandraCenter for Medical Mycology, Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
Thomas McCormickCenter for Medical Mycology, Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
Masaru MiyagiDepartment of Pharmacology, Case Western Reserve University, Cleveland, Ohio, USA.
Mahmoud A GhannoumCenter for Medical Mycology, Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA mahmoud.ghannoum@case.edu.
Case Western Reserve University · USUniversity Hospitals of Cleveland · US

Funding

Polymicrobial interactions in Crohn's DiseaseR01AI145289 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI GHANNOUM, MAHMOUD A · 2019 to 2023
$3.1M
NIAID NIH HHS R01 AI145289
6 · The paper itself

Abstract

Dysbiosis of the gut microbiome has been implicated in inflammatory bowel diseases. We have shown that levels of

Indexed as

AntibiosisBiofilmsCandida albicansCandida tropicalisEscherichia coliMicrobial InteractionsProbioticsSerratia marcescensbiofilmsCandida albicansCandida tropicalisprobiotics

Identifiers

PMID30940712
PMCPMC6456750
OpenAlexW2932060316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.